ArticleJournal of immunotherapy (Hagerstown, Md. : 1997)2009
IRF9 is a key factor for eliciting the antiproliferative activity of IFN-alpha.
Takaya Tsuno et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
39 papers cite it
this paperpooled itcites it